Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Footer-level revision notices were updated: a new 'Revision: v3.3.3' was added and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items were removed. No study content or results sections were changed.
    Difference
    0.1%
    Check dated 2025-12-22T22:46:10.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updated for the page; no substantive changes to study details or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:41:36.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a note that publications are provided voluntarily and relate to the study results, and updated the revision to v3.3.1. The previous wording claimed publications were about the study results and referenced v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T13:35:45.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH Clinical Center operating status has been removed, with no change to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:34:12.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The two screenshots show the same study record with identical sections and data, with only layout and formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:14:14.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and version bump to v3.2.0; removed the previous v3.1.0 version reference.
    Difference
    2%
    Check dated 2025-10-05T10:04:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.